Label: DR.NUELL VANISHING BB- glycerin, adenosine cream

  • Category: HUMAN OTC DRUG LABEL

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated November 10, 2019

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    arbutin, adenosine, ethylhexyl methoxycinnamate, titanium dioxide

  • PURPOSE

    brightening

    wrinkle improvement

    UV protection

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children

  • INDICATIONS & USAGE

    use BB cream alone, or take the appropriate amount and apply it evenly along with the skin texture in the last stage of skin care

  • WARNINGS

    1) if there is any abnormal symptom or side effect, such as red spot, swelling and itching when using cosmetlcs or after using due to direct sunlight, consult dermatologists
    2) Do not use for wounded areas
    3) Precautions for storage and handling
    keep out of reach of children, store away from direct sunlight
    4) avoid the eye area

  • INACTIVE INGREDIENT

    water, cyclopentasiloxane, dimethicone, etc.

  • DOSAGE & ADMINISTRATION

    For external use only

  • PRINCIPAL DISPLAY PANEL

    label

  • INGREDIENTS AND APPEARANCE
    DR.NUELL VANISHING BB 
    glycerin, adenosine cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:73430-0007
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN7 g  in 100 mL
    ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) ADENOSINE0.04 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    PROPANEDIOL (UNII: 5965N8W85T)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:73430-0007-130 mL in 1 TUBE; Type 0: Not a Combination Product11/01/2019
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart34711/01/2019
    Labeler - Apharm Co., Ltd. (689054266)
    Registrant - Apharm Co., Ltd. (689054266)
    Establishment
    NameAddressID/FEIBusiness Operations
    APHARM Co., Ltd.689054266manufacture(73430-0007)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!